SOCIETY OF ONCOPLASTIC SURGERY (EIN 842267024) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2019

Principal Officer

JOY D'ALBORA

Phone

9724121099

Tax Period

2023-01-01 to 2023-12-31

SOCIETY OF ONCOPLASTIC SURGERY, founded in 2019, is a small nonprofit in the Health Care sector that reported $122K in total revenue in fiscal year 2023. Revenue fell 28% from the prior year — a significant decline worth monitoring.

Mission

THE SOCIETY OF ONCOPLASTIC SURGERY (SOS) PROVIDES AN OPPORTUNITY FOR SURGEONS TO IMMERSE THEMSELVES IN KNOWLEDGE ALONGSIDE WORLD-RENOWNED PIONEERS IN ONCOPLASTIC SURGERY. THE SOS FOCUSES ON THE IMPORTANCE OF THE MULTI-DISCIPLINARY APPROACH IN THE PRE-OP ASSESSMENT AND THE PRACTICAL ELEMENTS OF HOW TO PERFORM ONCOPLASTIC PROCEDURES. DIDACTIC LECTURES FEATURE EXPERTS IN BREAST SURGERY (ONCOLOGY & AESTHETIC/RECONSTRUCTIVE SURGERY), RADIOLOGY, RADIATION ONCOLOGY, PATHOLOGY, AND THE PSYCHOSOCIAL ASPECTS OF BREAST CARE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $122,051

Investment Income $0

Other Revenue $0

TOTAL REVENUE $122,051

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $130,208

Other Expenses $132,696

TOTAL EXPENSES $132,696

Year-over-Year Comparison

	2023	2022	Change
Revenue	$122,051	$168,560	-0.3%
Expenses	$132,696	$114,154	+0.2%
Net Income	$-10,645	$54,406	-1.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JOY D'ALBORA	EXECUTIVE DI	5.00	Officer	$0	$0	$0
GAIL LEBOVIC	BOARD CHAIR	5.00	Officer	$0	$0	$0
MAURICE LA VERDURE	TREASURER	2.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	$122,051	$132,696	$44,907	$-10,645
2022	$168,560	$114,154	$55,552	$54,406

SOCIETY OF ONCOPLASTIC SURGERY